Laserfiche WebLink
with creditors or other similar relief under the federal bankruptcy laws or under any other <br />applicable law of the United States of America or any state thereof, (vi) consents to the <br />appointment of a trustee or receiver for it or for a substantial part of its property, (vii) <br />takes any organizational action (with respect to the Developer or the Corporate <br />Guarantor) for the purpose of effecting or consenting to any of the foregoing. <br />(f) Representations and Warranties. If any representation or warranty <br />contained herein or in any other Loan Document, or in any letter, financial statement, or <br />certificate furnished or to be furnished to the HRA, proves to be false in any material <br />respect as of the date this Loan Agreement is executed or at the time such letter or <br />certificate is delivered to the HRA. <br />(g) Completion of Minimum Improvements. If the Developer has not <br />Completed the Minimum Improvements on or before the Completion Date. <br />Section 7.2 Effect of Event of Default. If any Event of Default shall occur, the <br />Notes shall, at the HRA's option, become immediately due and payable, in full, by giving the <br />Developer written notice of such acceleration. In addition, and without limiting any other <br />remedy available to the HRA, upon the occurrence of an event set forth in Section 7.1(e) above, <br />all sums outstanding on the Notes shall become immediately due and payable automatically <br />without notice to the Developer. If any Event of Default shall occur, the HRA may, at its option, <br />exercise any of its available rights and remedies under the Loan Documents and under any <br />applicable law, rule or regulation, including, without limitation, the following: <br />2695614v12 <br />(a) terminate the HRA's obligation to Advance any further sums <br />pursuant hereto; or <br />(b) declare all amounts advanced against the Notes, plus all accrued <br />but unpaid interest thereon, to be immediately due and payable, and demand payment in <br />full of the then - outstanding principal balance of the Notes and all accrued but unpaid <br />interest thereon. <br />Section 7.3 No Remedy Exclusive. No remedy herein conferred upon or <br />reserved to the HRA is intended to be exclusive of any other available remedy or remedies, but <br />each and every such remedy shall be cumulative and shall be in addition to every other remedy <br />given under this Loan Agreement, the other Loan Documents, the Development Agreement now <br />or hereafter existing at law or in equity or by statute. No delay or omission to exercise any right <br />or power accruing upon any default shall impair any such right or power or shall be construed to <br />be a waiver thereof, but any such right and power may be exercised from time to time and as <br />often as may be deemed expedient. <br />ARTICLE VIII <br />MISCELLANEOUS <br />Section 8.1 Conflicts of Interest. No member of the governing body or other <br />official of the HRA shall participate in any decision relating to this Loan Agreement which <br />affects his or her personal interests or the interests of any corporation, partnership or association <br />A -14 <br />